Document is current
Any future updates will be listed below
-
Authors
Kaiser, Ulrich
Vehling-Kaiser, Ursula
Hoffmann, Ana
Kaiser, Felix
Rechenmacher, Michael
Kaiser, Eleène
Chalupper, Romina
Fiedler, Moritz
Kaiser, Florian
-
Funding
Funding for this research was provided by:
Bavarian State Ministry of Health and Care (G46e-K9200.1-2022/35 − 2, G46e-K9200.1-2022/35 − 2, G46e-K9200.1-2022/35 − 2)
- License Information
-
More Information
Article History
Received: 1 January 2025
Accepted: 24 September 2025
First Online: 15 October 2025
Declarations
:
: The project was approved by the Ethics Committee of the University of Regensburg (No. 22-3012-101) and was registered in the German Register of Clinical Studies (DRKS-ID: DRKS00031613) and the Display portal of the Center for Clinical Studies of the University Hospital Regensburg (Z-2022-1734-6).
: Not applicable.
: UK, UVK, AH, FK, MR, EK, RC, and MF declare no competing interests; FK has conducted consulting work for Abbvie, Astellas, BeiGene, Gilead, GSK, Janssen, Lilly, Novartis, Pierrre Fabre, Sanofi, Servier, and Elsevier.
